Number one was asthma, number two was developmental delays, number three was 400-fold increases in rare childhood cancers in the last eight to 10, 15 years.
Número uno era asma, número dos era retrasos en el desarrollo, número tres era el crecimiento en 400 veces de cánceres raros en la niñez entre